Loading…
Trends in Perinatal Group B Streptococcal Disease — United States, 2000–2006
Group B Streptococcus (GBS) is a leading infectious cause of neonatal morbidity and mortality in the United States. The bacterium, a common colonizer of the maternal genital tract, can infect the fetus during gestation, causing fetal death. GBS also can be acquired by the fetus during passage throug...
Saved in:
| Published in: | MMWR. Morbidity and mortality weekly report 2009-02, Vol.58 (5), p.109-112 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | 112 |
| container_issue | 5 |
| container_start_page | 109 |
| container_title | MMWR. Morbidity and mortality weekly report |
| container_volume | 58 |
| creator | Apostol, M Gershman, K Petit, S Arnold, K Harrison, L Lynfield, R Morin, C Baumbach, J Zansky, S Thomas, A Schaffner, W Schrag, S.J Zell, E.R Lewis, M.M Muhammad, R.D |
| description | Group B Streptococcus (GBS) is a leading infectious cause of neonatal morbidity and mortality in the United States. The bacterium, a common colonizer of the maternal genital tract, can infect the fetus during gestation, causing fetal death. GBS also can be acquired by the fetus during passage through the birth canal or after delivery. Infection commonly manifests as meningitis, pneumonia, or sepsis. In 2002, CDC, the American College of Obstetricians and Gynecologists, and the American Academy of Pediatrics issued revised guidelines for prevention of early-onset GBS disease (i.e., in infants aged |
| format | article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_66919480</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A196383454</galeid><jstor_id>24830707</jstor_id><sourcerecordid>A196383454</sourcerecordid><originalsourceid>FETCH-LOGICAL-g254t-c115fb57c1d507272d4f7188280674ed5e1764e34178d889453ef92031a7881a3</originalsourceid><addsrcrecordid>eNptkc9qGzEQxpfQ0DhuHyFlTzl1g0Z_VtIxdZs_EIihMeS2KLuzjsJaciXtobe8Q_KEeZIo2CkNeOYw8M3v-xiYvWICgotK1XD7qZgQ4LqioMVBcRjjA3krRj4XB6ApcBB6UsxvAroultaVcwzWmWSG8jz4cV3-KH-ngOvkW9-2Wf1pI5qI5cvjc7lwNmGXAZMwfi9pDn55fMqj_lLs92aI-HU7p8Xi7NfN7KK6uj6_nJ1eVUsqeKpaANHfCdlCJ4ikkna8l6AUVaSWHDuBIGuOjINUnVKaC4a9poSBkUqBYdPieJO7Dv7PiDE1KxtbHAbj0I-xqWsNmiuSwWoDLs2AjXW9T8G0S3QYzOAd9jbLp6BrphgXPPMnO_jcHa5su9Nw_J_hHs2Q7qMfxmS9ix_Bb9uTx7sVds062JUJf5v3b2TgaAM8xOTDvz3lihFJJHsFT-eMzQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66919480</pqid></control><display><type>article</type><title>Trends in Perinatal Group B Streptococcal Disease — United States, 2000–2006</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>Social Science Premium Collection (Proquest) (PQ_SDU_P3)</source><creator>Apostol, M ; Gershman, K ; Petit, S ; Arnold, K ; Harrison, L ; Lynfield, R ; Morin, C ; Baumbach, J ; Zansky, S ; Thomas, A ; Schaffner, W ; Schrag, S.J ; Zell, E.R ; Lewis, M.M ; Muhammad, R.D</creator><creatorcontrib>Apostol, M ; Gershman, K ; Petit, S ; Arnold, K ; Harrison, L ; Lynfield, R ; Morin, C ; Baumbach, J ; Zansky, S ; Thomas, A ; Schaffner, W ; Schrag, S.J ; Zell, E.R ; Lewis, M.M ; Muhammad, R.D ; Centers for Disease Control and Prevention (CDC)</creatorcontrib><description>Group B Streptococcus (GBS) is a leading infectious cause of neonatal morbidity and mortality in the United States. The bacterium, a common colonizer of the maternal genital tract, can infect the fetus during gestation, causing fetal death. GBS also can be acquired by the fetus during passage through the birth canal or after delivery. Infection commonly manifests as meningitis, pneumonia, or sepsis. In 2002, CDC, the American College of Obstetricians and Gynecologists, and the American Academy of Pediatrics issued revised guidelines for prevention of early-onset GBS disease (i.e., in infants aged <7 days). These guidelines recommended universal screening of all pregnant women for rectovaginal GBS colonization at 35-37 weeks' gestation and administration of intrapartum antibiotic prophylaxis (IAP) to carriers. A report published in 2007 indicated that, during 2003-2005, the overall rate of early-onset GBS disease increased, whereas incidence of late-onset GBS disease (i.e., in infants aged 7-89 days) remained stable. This report updates the 2007 report by incorporating 2006 data from the Active Bacterial Core surveillance (ABCs) system. The updated analysis revealed an increase in the overall rate of early-onset GBS disease from 2003 to 2006, driven by an increasing incidence among black term infants. Late-onset GBS disease incidence among black infants, which had increased during 2003-2005, declined in 2006. Continued monitoring is needed to follow trends in early-onset GBS disease among black infants to determine whether additional interventions are warranted.</description><identifier>ISSN: 0149-2195</identifier><identifier>ISSN: 1545-861X</identifier><identifier>EISSN: 1545-861X</identifier><identifier>PMID: 19214159</identifier><language>eng</language><publisher>United States: Coordinating Center for Health Information and Service, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services</publisher><subject>Age of Onset ; Black or African American ; Black People ; Coccidioidomycosis ; Demographic aspects ; Diagnosis ; Disease incidence rates ; Epidemiology ; Female ; Gestational Age ; Humans ; Incidence ; Infant, Newborn ; Infant, Premature ; Infants ; Infections ; Infectious Disease Transmission, Vertical ; Mass Screening ; Notifiable diseases ; Population Surveillance ; Pregnancy ; Pregnancy Complications, Infectious - diagnosis ; Preventive medicine ; Public health ; Streptococcal Infections - epidemiology ; Streptococcal Infections - ethnology ; Streptococcal Infections - transmission ; Streptococcus agalactiae ; Surveillance ; United States - epidemiology ; Vivipary</subject><ispartof>MMWR. Morbidity and mortality weekly report, 2009-02, Vol.58 (5), p.109-112</ispartof><rights>COPYRIGHT 2009 U.S. Government Printing Office</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/24830707$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/24830707$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,33612,58238,58471</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19214159$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Apostol, M</creatorcontrib><creatorcontrib>Gershman, K</creatorcontrib><creatorcontrib>Petit, S</creatorcontrib><creatorcontrib>Arnold, K</creatorcontrib><creatorcontrib>Harrison, L</creatorcontrib><creatorcontrib>Lynfield, R</creatorcontrib><creatorcontrib>Morin, C</creatorcontrib><creatorcontrib>Baumbach, J</creatorcontrib><creatorcontrib>Zansky, S</creatorcontrib><creatorcontrib>Thomas, A</creatorcontrib><creatorcontrib>Schaffner, W</creatorcontrib><creatorcontrib>Schrag, S.J</creatorcontrib><creatorcontrib>Zell, E.R</creatorcontrib><creatorcontrib>Lewis, M.M</creatorcontrib><creatorcontrib>Muhammad, R.D</creatorcontrib><creatorcontrib>Centers for Disease Control and Prevention (CDC)</creatorcontrib><title>Trends in Perinatal Group B Streptococcal Disease — United States, 2000–2006</title><title>MMWR. Morbidity and mortality weekly report</title><addtitle>MMWR Morb Mortal Wkly Rep</addtitle><description>Group B Streptococcus (GBS) is a leading infectious cause of neonatal morbidity and mortality in the United States. The bacterium, a common colonizer of the maternal genital tract, can infect the fetus during gestation, causing fetal death. GBS also can be acquired by the fetus during passage through the birth canal or after delivery. Infection commonly manifests as meningitis, pneumonia, or sepsis. In 2002, CDC, the American College of Obstetricians and Gynecologists, and the American Academy of Pediatrics issued revised guidelines for prevention of early-onset GBS disease (i.e., in infants aged <7 days). These guidelines recommended universal screening of all pregnant women for rectovaginal GBS colonization at 35-37 weeks' gestation and administration of intrapartum antibiotic prophylaxis (IAP) to carriers. A report published in 2007 indicated that, during 2003-2005, the overall rate of early-onset GBS disease increased, whereas incidence of late-onset GBS disease (i.e., in infants aged 7-89 days) remained stable. This report updates the 2007 report by incorporating 2006 data from the Active Bacterial Core surveillance (ABCs) system. The updated analysis revealed an increase in the overall rate of early-onset GBS disease from 2003 to 2006, driven by an increasing incidence among black term infants. Late-onset GBS disease incidence among black infants, which had increased during 2003-2005, declined in 2006. Continued monitoring is needed to follow trends in early-onset GBS disease among black infants to determine whether additional interventions are warranted.</description><subject>Age of Onset</subject><subject>Black or African American</subject><subject>Black People</subject><subject>Coccidioidomycosis</subject><subject>Demographic aspects</subject><subject>Diagnosis</subject><subject>Disease incidence rates</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Gestational Age</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infant, Newborn</subject><subject>Infant, Premature</subject><subject>Infants</subject><subject>Infections</subject><subject>Infectious Disease Transmission, Vertical</subject><subject>Mass Screening</subject><subject>Notifiable diseases</subject><subject>Population Surveillance</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Infectious - diagnosis</subject><subject>Preventive medicine</subject><subject>Public health</subject><subject>Streptococcal Infections - epidemiology</subject><subject>Streptococcal Infections - ethnology</subject><subject>Streptococcal Infections - transmission</subject><subject>Streptococcus agalactiae</subject><subject>Surveillance</subject><subject>United States - epidemiology</subject><subject>Vivipary</subject><issn>0149-2195</issn><issn>1545-861X</issn><issn>1545-861X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNptkc9qGzEQxpfQ0DhuHyFlTzl1g0Z_VtIxdZs_EIihMeS2KLuzjsJaciXtobe8Q_KEeZIo2CkNeOYw8M3v-xiYvWICgotK1XD7qZgQ4LqioMVBcRjjA3krRj4XB6ApcBB6UsxvAroultaVcwzWmWSG8jz4cV3-KH-ngOvkW9-2Wf1pI5qI5cvjc7lwNmGXAZMwfi9pDn55fMqj_lLs92aI-HU7p8Xi7NfN7KK6uj6_nJ1eVUsqeKpaANHfCdlCJ4ikkna8l6AUVaSWHDuBIGuOjINUnVKaC4a9poSBkUqBYdPieJO7Dv7PiDE1KxtbHAbj0I-xqWsNmiuSwWoDLs2AjXW9T8G0S3QYzOAd9jbLp6BrphgXPPMnO_jcHa5su9Nw_J_hHs2Q7qMfxmS9ix_Bb9uTx7sVds062JUJf5v3b2TgaAM8xOTDvz3lihFJJHsFT-eMzQ</recordid><startdate>20090213</startdate><enddate>20090213</enddate><creator>Apostol, M</creator><creator>Gershman, K</creator><creator>Petit, S</creator><creator>Arnold, K</creator><creator>Harrison, L</creator><creator>Lynfield, R</creator><creator>Morin, C</creator><creator>Baumbach, J</creator><creator>Zansky, S</creator><creator>Thomas, A</creator><creator>Schaffner, W</creator><creator>Schrag, S.J</creator><creator>Zell, E.R</creator><creator>Lewis, M.M</creator><creator>Muhammad, R.D</creator><general>Coordinating Center for Health Information and Service, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services</general><general>U.S. Government Printing Office</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20090213</creationdate><title>Trends in Perinatal Group B Streptococcal Disease — United States, 2000–2006</title><author>Apostol, M ; Gershman, K ; Petit, S ; Arnold, K ; Harrison, L ; Lynfield, R ; Morin, C ; Baumbach, J ; Zansky, S ; Thomas, A ; Schaffner, W ; Schrag, S.J ; Zell, E.R ; Lewis, M.M ; Muhammad, R.D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g254t-c115fb57c1d507272d4f7188280674ed5e1764e34178d889453ef92031a7881a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Age of Onset</topic><topic>Black or African American</topic><topic>Black People</topic><topic>Coccidioidomycosis</topic><topic>Demographic aspects</topic><topic>Diagnosis</topic><topic>Disease incidence rates</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Gestational Age</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infant, Newborn</topic><topic>Infant, Premature</topic><topic>Infants</topic><topic>Infections</topic><topic>Infectious Disease Transmission, Vertical</topic><topic>Mass Screening</topic><topic>Notifiable diseases</topic><topic>Population Surveillance</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Infectious - diagnosis</topic><topic>Preventive medicine</topic><topic>Public health</topic><topic>Streptococcal Infections - epidemiology</topic><topic>Streptococcal Infections - ethnology</topic><topic>Streptococcal Infections - transmission</topic><topic>Streptococcus agalactiae</topic><topic>Surveillance</topic><topic>United States - epidemiology</topic><topic>Vivipary</topic><toplevel>online_resources</toplevel><creatorcontrib>Apostol, M</creatorcontrib><creatorcontrib>Gershman, K</creatorcontrib><creatorcontrib>Petit, S</creatorcontrib><creatorcontrib>Arnold, K</creatorcontrib><creatorcontrib>Harrison, L</creatorcontrib><creatorcontrib>Lynfield, R</creatorcontrib><creatorcontrib>Morin, C</creatorcontrib><creatorcontrib>Baumbach, J</creatorcontrib><creatorcontrib>Zansky, S</creatorcontrib><creatorcontrib>Thomas, A</creatorcontrib><creatorcontrib>Schaffner, W</creatorcontrib><creatorcontrib>Schrag, S.J</creatorcontrib><creatorcontrib>Zell, E.R</creatorcontrib><creatorcontrib>Lewis, M.M</creatorcontrib><creatorcontrib>Muhammad, R.D</creatorcontrib><creatorcontrib>Centers for Disease Control and Prevention (CDC)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>MMWR. Morbidity and mortality weekly report</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Apostol, M</au><au>Gershman, K</au><au>Petit, S</au><au>Arnold, K</au><au>Harrison, L</au><au>Lynfield, R</au><au>Morin, C</au><au>Baumbach, J</au><au>Zansky, S</au><au>Thomas, A</au><au>Schaffner, W</au><au>Schrag, S.J</au><au>Zell, E.R</au><au>Lewis, M.M</au><au>Muhammad, R.D</au><aucorp>Centers for Disease Control and Prevention (CDC)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trends in Perinatal Group B Streptococcal Disease — United States, 2000–2006</atitle><jtitle>MMWR. Morbidity and mortality weekly report</jtitle><addtitle>MMWR Morb Mortal Wkly Rep</addtitle><date>2009-02-13</date><risdate>2009</risdate><volume>58</volume><issue>5</issue><spage>109</spage><epage>112</epage><pages>109-112</pages><issn>0149-2195</issn><issn>1545-861X</issn><eissn>1545-861X</eissn><abstract>Group B Streptococcus (GBS) is a leading infectious cause of neonatal morbidity and mortality in the United States. The bacterium, a common colonizer of the maternal genital tract, can infect the fetus during gestation, causing fetal death. GBS also can be acquired by the fetus during passage through the birth canal or after delivery. Infection commonly manifests as meningitis, pneumonia, or sepsis. In 2002, CDC, the American College of Obstetricians and Gynecologists, and the American Academy of Pediatrics issued revised guidelines for prevention of early-onset GBS disease (i.e., in infants aged <7 days). These guidelines recommended universal screening of all pregnant women for rectovaginal GBS colonization at 35-37 weeks' gestation and administration of intrapartum antibiotic prophylaxis (IAP) to carriers. A report published in 2007 indicated that, during 2003-2005, the overall rate of early-onset GBS disease increased, whereas incidence of late-onset GBS disease (i.e., in infants aged 7-89 days) remained stable. This report updates the 2007 report by incorporating 2006 data from the Active Bacterial Core surveillance (ABCs) system. The updated analysis revealed an increase in the overall rate of early-onset GBS disease from 2003 to 2006, driven by an increasing incidence among black term infants. Late-onset GBS disease incidence among black infants, which had increased during 2003-2005, declined in 2006. Continued monitoring is needed to follow trends in early-onset GBS disease among black infants to determine whether additional interventions are warranted.</abstract><cop>United States</cop><pub>Coordinating Center for Health Information and Service, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services</pub><pmid>19214159</pmid><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0149-2195 |
| ispartof | MMWR. Morbidity and mortality weekly report, 2009-02, Vol.58 (5), p.109-112 |
| issn | 0149-2195 1545-861X 1545-861X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_66919480 |
| source | JSTOR Archival Journals and Primary Sources Collection; Social Science Premium Collection (Proquest) (PQ_SDU_P3) |
| subjects | Age of Onset Black or African American Black People Coccidioidomycosis Demographic aspects Diagnosis Disease incidence rates Epidemiology Female Gestational Age Humans Incidence Infant, Newborn Infant, Premature Infants Infections Infectious Disease Transmission, Vertical Mass Screening Notifiable diseases Population Surveillance Pregnancy Pregnancy Complications, Infectious - diagnosis Preventive medicine Public health Streptococcal Infections - epidemiology Streptococcal Infections - ethnology Streptococcal Infections - transmission Streptococcus agalactiae Surveillance United States - epidemiology Vivipary |
| title | Trends in Perinatal Group B Streptococcal Disease — United States, 2000–2006 |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T16%3A04%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trends%20in%20Perinatal%20Group%20B%20Streptococcal%20Disease%20%E2%80%94%20United%20States,%202000%E2%80%932006&rft.jtitle=MMWR.%20Morbidity%20and%20mortality%20weekly%20report&rft.au=Apostol,%20M&rft.aucorp=Centers%20for%20Disease%20Control%20and%20Prevention%20(CDC)&rft.date=2009-02-13&rft.volume=58&rft.issue=5&rft.spage=109&rft.epage=112&rft.pages=109-112&rft.issn=0149-2195&rft.eissn=1545-861X&rft_id=info:doi/&rft_dat=%3Cgale_proqu%3EA196383454%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g254t-c115fb57c1d507272d4f7188280674ed5e1764e34178d889453ef92031a7881a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=66919480&rft_id=info:pmid/19214159&rft_galeid=A196383454&rft_jstor_id=24830707&rfr_iscdi=true |